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Background: Ionizing radiation is widely used for treatment of cancer. However, one of the
limitations of using radiation is its toxic effects on normal tissue. Radiation damage to
normal tissue can be partially reduced by the use of radio-protectors that scavenge free
radicals produced during radiation. Recently, interest has increased in the development
of potential drug of plant origin for the modification of radiation effects and has an
advantage over the synthetic compounds in term of low or no toxicity and with minimum
side effects. Propolis is apicultural product which is composed of nutritionally valuable
substances and contains considerable amounts of polyphenol substances. Flavonoids and
phenolic acids are the major classes of polyphenolic compounds. Because of its broad
spectrum biological properties, the interest in propolis as harmless medicine has been
increased.
Aim of the work: The present study has been undertaken to evaluate the radio-protective
effect of propolis supplementation in breast cancer (BC) patients undergoing radiotherapy.
Subjects and methods: This study included 135 subjects divided into three main groups:
Group I: 45 healthy females served as control group of matched age and menopausal status
with the next malignant groups. Group II: 45 chemotherapy received breast cancer patients
followed by radiation therapy only. Group III: 45 chemotherapy received breast cancer
patients followed by radiation therapy plus propolis supplements. Two venous blood
samples were collected from both breast cancer patients groups (Before and after radio-
therapy) and one blood sample from matched controls. DNA damage in mononuclear cells
was assessed by alkaline Comet assay. Serum was separated to measure ribonucleotide
reductase M2 subunit (RRM2) by enzyme linked immunossorbent assay (ELISA). Malo-
naldhyde (MDA), total antioxidant capacity (TAC) and iron were assayed by colorimetric
method. One ml blood sample was collected into EDTA tubes for complete blood picture
analysis.
Results: The present study showed that radiotherapy is accompanied by significant increase
in Comet tail parameters (Tail length, % Tail DNA, Tail moment) in peripheral bloodm (S.A. El-Benhawy).
gyptian Society of Radiation Sciences and Applications.
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propolis plus radiotherapy, propolis have the ability to reduce significantly the radiation
induced DNA damage. Concerning RRM2 subunit, it was found that, although radiotherapy
significantly down regulate RRM2 protein but still significantly higher than normal control
value. On the other hand, the supplementation of propolis during radiotherapy caused a
significant down regulation of RRM2 level and became within the normal control level.
Furthermore, radiotherapy is accompanied by significant increase in serum MDA and
significant decrease in serum TAC while after propolis supplementation plus radiotherapy,
serum MDA and serum TAC significantly improved. Regarding serum iron and hemato-
logical parameters including hemoglobin (HB) concentration, white blood cells (WBCs) and
platelets counts were significantly decreased after radiotherapy treatment alone while
after radiotherapy plus propolis, these parameters significantly increased and became
within the normal control level.
Conclusions: Supplementation of propolis with radiotherapy treatment offers a quite
measurable protection against DNA damage caused by ionizing radiation in BC patients
leukocytes and inhibits RRM2 overexpression. Moreover, propolis has beneficial effects on
the serum antioxidant capacity and improves the digestive utilization of iron and the
regeneration efficiency of hemoglobin. Larger prospective studies are required to confirm
our findings.
Copyright © 2016, The Egyptian Society of Radiation Sciences and Applications. Production
and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Radiotherapy is the most common modality for treating
human cancers. Eighty percent of cancer patients need
radiotherapy at sometime or another, either for curative or
palliative purpose (Paul, Unnikrishnan, & Nagappa, 2011).
Radiation therapy destroys cells in the exposed area by
damaging their geneticmaterial (Sankaranarayanan, 2006). As
radiation effects do not discriminate between normal and
malignant cells and tissue, patients may experience symp-
toms during the course of therapy for a few weeks after
therapy or months or years later (Karbownik & Reiter, 2000).
Several modalities and clinical approaches have been made
to reduce these early and late complications of the radiother-
apies and one among them is the use of an effective and non-
toxic radio-protector (Kim, Seong, & Youn, 2006). Radio-
protectors are compounds that are designed to reduce the
damage in normal tissue caused by radiation. These com-
pounds are often antioxidants andmust be present before or at
the time of radiation for their effectiveness (Maurya,
Devasagayam, & Nair, 2006). To overcome harmful effects of
synthetic compounds, many naturally occurring substances
have been studied as candidates for effective radioprotection.
These include polyphenols and honeybee products such as
propolis. The awareness of their radio-protective properties has
increased over the last decade, and their effects have exten-
sively been studied in vitro and in vivo (Benkovic et al., 2009).
Propolis is adhesive resinous substance manufactured by
honey bees from leaf, bud and sap of trees and flower blos-
soms. Major constituents of propolis are flavonoids, organic
acids, phenols, various kinds of enzymes, vitamins and min-
erals (Bankova, 2005). Because of its broad spectrum of bio-
logical properties the interest in propolis as harmlessmedicine has been increased. Propolis and its active sub-
stances flavonoids showed antibacterial, analgesic/anti-
inflammatory, antioxidant, immune-enhancement, anti-pro-
liferative activity in cultured human tumor cells and anti-
tumor activity in mice. Antioxidant activity of flavonoids is
based on ability of direct free radicals scavenging or stabilizing
the reactive oxygen species (ROS) by interacting with the
reactive compound of the radical (Benkovic et al., 2008). Fla-
vonoids can also increase the function of the endogenous
antioxidant enzyme systems; superoxide dismutase, catalase,
glutathione peroxidase and glutathione reductase (Russo
et al., 2000). Moreover, immune activity boosted by propolis
and related compounds enhances haemopoietic regeneration
and survival following radiation-induced lympho- andmyelo-
supression (Orsolic et al., 2007). Reports of other authors
confirm the protective effect of propolis on bone marrow and
lymphoid tissue ofmice treatedwith cytotoxic drugs (Lahouel,
Boulkour, Segueni, & Fillastre, 2004; Sadzuka, Sugiyama,
Shimoi, Kinae, & Hirota, 1997).
Several studies have demonstrated higher initial and/or
residual DNA damage and lower repair rate following irradi-
ation of peripheral blood lymphocytes (PBL) in vitro as
compared to controls (Palyvoda, Polanska, Wygoda, &
Rzeszowska-Wolny, 2003; Lou et al., 2007). Furthermore,
many other studies have examined PBL of cancer patients
who are undergoing chemotherapy or radiotherapy to see if
the effect of radiation or anti-neoplastic drugs results in
lymphocyte DNA damage in vivo; this approach is used as a
surrogate indicator of how the tumor cells may be affected.
These studies have shown that DNA damage is increased and/
or DNA repair capacity is decreased in PBL samples from pa-
tients with a variety of cancers (Almeida, Duarte, Steward, &
Jones, 2006; Nadin, Vargas-Roig, Drago, Ibarra,& Ciocca, 2006).
J o u rn a l o f R a d i a t i o n R e s e a r c h and A p p l i e d S c i e n c e s 9 ( 2 0 1 6 ) 4 3 1e4 4 0 433Among the fundamental processes that influence
radiation-induced cell death is DNA repair; a critical molecule
in this process is ribonucleotide reductase (RR). RR catalyzes
the reduction of ribonucleotides to deoxyribonucleotides and
thus provides an essential component for DNA synthesis and
repair. RR is composed of two homodimer subunits. The R1
subunit (composed of two molecules of hRRM1) contains the
ribonucleotide binding sites and allosteric effector sites. The
R2 subunit, which contains a non heme iron complexedwith a
tyrosyl free radical and is essential for catalytic activity, was
initially defined as a homodimer of hRRM2 (Barker et al., 2006).
Kuo, Hwang, Sosnay, Kunugi, and Kinsella (2003) showed that
the over-expression of the M1 subunit has no effect on radio-
sensitivity while over-expression of the M2 subunit protects
against radiation-induced cell death, consistent with the M2
subunit of RR serving as a potential target for radio-
sensitization.
The main target of the present study was to evaluate the
level of DNA damage in circulating mononuclear cells, ribo-
nucleotide reductase M2 subunit, total antioxidant capacity,
lipid peroxidation as well as hematological patterns in
chemotherapy received BC patients before and after
completing radiotherapy alone or radiotherapy plus propolis
capsules as a radio-protective agent.2. Subjects and methods
This study included 135 females divided into three main
groups:
Group I: 45 healthy females of matched age and meno-
pausal status with the next malignant groups served as
control group.
Group II: 45 chemotherapy received breast cancer patients
followed by radiation therapy only.
Group III: 45 chemotherapy received breast cancer patients
followed by radiation therapy plus propolis supplements.
Patients in group III supplemented with propolis capsules
(400 mg, 3 times daily) for 10 consecutive days before radio-
therapy, during the course of radiation treatment and 10 days
after completing the radiotherapy.
Patients were recruited from Cancer Management and
Research Department, Medical Research Institute, Alexandria
University. Awritten consent from all subjects participating in
the study was taken according to the declaration of Helsinki
and approved by the ethical committee of the Medical
Research Institute. All investigations had been carried out in
accordance with a high standard of ethics.
All breast cancer patients surgically treated by Modified
Radical Mastectomy followed by adjuvant chemotherapy
consisting of 6 cycles of FAC (5-Flourouracil, Adriamycin and
Cyclophosfamide). After finishing chemotherapy, breast can-
cer patients exposed to radiation therapy using a linear
accelerator (LINAC)which customizes high energy X-rays. The
dose delivered was 50 Gray over a period of 25 days in a daily
fraction of 2 Gray delivered five times a week. Exclusion
criteria including metastatic patients at the time of diagnosis
and patients exposed to radiotherapy before surgery.2.1. Blood samples collection
Two venous blood samples were collected from breast cancer
patients (Before and after radiotherapy) and one blood sample
frommatched controls. About 10 ml fasting venous blood was
drawn and divided into two aliquots. The first aliquot was
added to heparinized tubes to isolate mononuclear cells by
Ficoll-Paque PLUS density gradient centrifugation and pro-
cessed immediately within a maximum of 1 h period after
collection by mean of the alkaline Comet assay to detect DNA
damage in peripheral blood mononuclear cells (Cell Biolabs,
USA). The second aliquot about 5 ml of venous blood was
added to serum separating tube. Blood sample was allowed to
clot for 30 min before centrifugation, centrifuged at 3000 rpm
for 10 min to isolate serum. The serum was stored at 80 C
until used to assay circulating levels of ribonucleotide reduc-
tase R2 subunit (RRM2) by ELISA according to the manufac-
turer's instructions (Life science, China). SerumMalonaldhyde
(MDA), total antioxidant capacity (TAC) and iron were assayed
by colorimetricmethods. 1ml blood samplewas collected into
EDTA tubes for complete blood picture analysis.
2.2. Statistical analysis
Statistical analysis was done using IBM SPSS statistics
“version 21”. Quantitative data were described by mean as
measure of central tendency and standard deviation and
minimum, maximum as measure of dispersion. Mixed design
ANOVA done to detect statistical significant difference in the
mean of quantitative variables before and after therapy and to
detect significant interaction among patients who received
radiotherapy alone and combined radiotherapy plus propolis
supplements. Independent sample t test and Mann Whitney
test were used to study statistical significance in the mean of
quantitative variables between two patients groups (radio-
therapy alone and combined radiotherapy plus propolis sup-
plements). Wilcoxon signed rank test was done to prove
statistical significance in the mean of quantitative variables
before and after treatment in each group of patients sepa-
rately. The KaplaneMeier curve was used to estimate the
disease free survival outcome of all patients, and groups were
compared with the log-rank statistic. All the statistical tests
were two tailed and done at P < 0.05 level of significance.3. Results
3.1. Patient demographics and tumor characteristics
Clinicopathological characteristics of the study patients were
represented in Table 1.
3.2. Comet tail parameters
Table 2 showed that, the mean values of Comet tail length in
the both chemotherapy received BC patients before treatment
either with radiotherapy alone or radiotherapy plus propolis
was nearly within the same range (P3 ¼ 0.279) and signifi-
cantly higher than control value (P1 < 0.001 and <0.001
respectively). The level of this parameter after radiotherapy
Table 1 e Patient demographics and tumor
characteristics.
Chemotherapy received
BC patients (n ¼ 90)
Age
Mean ± SD 53.72 ± 9.92
Range 29e67
Menopausal status
Pre 36 (40%)
Post 54 (60%)
Histological grade
II 78 (86.7%)
III 12 (13.3%)
Clinical stage
II 47 (52.2%)
III 43 (47.8%)
ER status
Positive 66 (73.3%)
Negative 24 (26.7%)
PR status
Positive 70 (77.8%)
Negative 20 (22.2%)
Her-2/neu expression
Positive 30 (33.3%)
Negative 60 (66.7%)
Vascular invasion
Yes 86 (95.6%)
No 4 (4.4%)
Tumor size (cm)
5 39 (43.3%)
>5 51 (56.7%)
Axillary lymph node involvement
Positive 68 (75.6%)
Negative 22 (24.4%)
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sponding value before treatment (P2 < 0.001) and still signifi-
cantly higher than normal control value (P1 < 0.001). On theTable 2e Statistical analyses of Comet tail parameters in norma
patients before and after treatment with either radiotherapy a
Control group (n ¼ 45) Chem
Radiotherapy alone g
Before
Tail length (mm)
Range 13.17e32.71 31.15e47.09
Mean ± SD 20.69 ± 6.01 38.99 ± 4.50
P1 <0.001
*
P2 <0.001*
P3
% Tail DNA
Range 1.31e8.91 4.25e31.41
Mean ± SD 4.83 ± 2.03 15.19 ± 6.77
P1 <0.001
*
P2 <0.001*
P3
Tail moment
Range 0.28e2.91 1.59e11.53
Mean ± SD 1.95 ± 0.68 6.90 ± 2.62
P1 <0.001
*
P2 <0.001*
P3other hand, after radiotherapy treatment plus propolis, Comet
tail lengthwas significantly decreased than the corresponding
value before treatment (P2 < 0.001) and became within the
normal control level (P1¼ 0.316). Moreover themean values of
this parameter after radiotherapy plus propolis was signifi-
cantly lower than after radiotherapy treatment alone
(P3 < 0.001).
Regarding % tail DNA, it was highly elevated before
radiotherapy treatment in both chemotherapy received BC
patients groups than in control group (P1 < 0.001 and <0.001
respectively). The level of this parameter after radiotherapy
treatment only was significantly increased than its corre-
sponding value before treatment (P2 < 0.001) and still
significantly higher than normal control value (P1 < 0.001).
On the other hand, after radiotherapy treatment plus prop-
olis, % tail DNA was significantly decreased than the corre-
sponding value before treatment (P2 < 0.001) and became
within the normal control level (P1 ¼ 0.423). Moreover the
mean values of this parameter after radiotherapy plus
propolis was significantly lower than after radiotherapy
treatment alone (P3 < 0.001).
With respect to Comet tail moment, it was highly elevated
before radiotherapy treatment in both chemotherapy received
BC patients groups than in control group (P1 < 0.001 and
<0.001 respectively). The level of tail moment after radio-
therapy treatment only was significantly increased than its
corresponding value before treatment (P2 < 0.001) and still
significantly higher than normal control value (P1 < 0.001). On
the other hand, after radiotherapy treatment plus propolis
supplements, Comet tail moment was significantly decreased
than the corresponding value before treatment (P2 < 0.001)
and became within the normal control level (P1 ¼ 0.521).
Moreover, the mean value of this parameter after radio-
therapy plus propolis was significantly lower than after
radiotherapy treatment alone (P3 < 0.001).l control subjects and chemotherapy received breast cancer
lone or radiotherapy plus propolis supplements.
otherapy received breast cancer patients
roup (n ¼ 45) Radiotherapy þ propolis group (n ¼ 45)
After Before After
52.3e131.96 31.67e48.82 15.21e34.42
78.55 ± 18.88 40.59 ± 4.9 22.73 ± 3.95
<0.001* <0.001* 0.316
<0.001*
0.279 <0.001*
24.24e70.50 3.89e26.93 2.21e10.14
39.87 ± 12.27 17.37 ± 6.13 6.14 ± 3.19
<0.001* <0.001* 0.423
<0.001*
0.157 <0.001*
12.98e93.09 1.25e10.94 0.53e4.72
32.56 ± 17.20 7.16 ± 2.75 2.29 ± 1.11
<0.001* <0.001* 0.521
<0.001*
0.804 <0.001*
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Table 3 showed that, the mean values of serum RRM2 subunit
in the both chemotherapy received BC patients before treat-
ment either with radiotherapy alone or radiotherapy plus
propolis supplements was nearly within the same range
(P3 ¼ 0.286) and significantly higher than control values
(P1 < 0.001 and <0.001 respectively). After radiotherapy treat-
ment only serum RRM2 was significantly decreased than its
corresponding value before treatment (P2 < 0.001) and still
significantly higher than normal control value (P1 < 0.001). On
the other hand, after radiotherapy treatment plus propolis the
level of RRM2 subunit was significantly decreased than the
corresponding value before treatment (P2 < 0.001) and became
within the normal control level (P1 ¼ 0.563). Moreover the
mean values of this enzyme subunit after radiotherapy plus
propolis was significantly lower than after radiotherapy
treatment alone (P3 < 0.001).
As presented in Table 3, the mean values of TAC in the two
chemotherapy received BC patients groups was significantly
less than normal control levels (P1 < 0.001 and <0.001
respectively). Serum TAC after radiotherapy treatment alone
was significantly decreased than corresponding values before
treatment (P2 ¼ 0.013) and was significantly lower than
normal control level (P1 < 0.001 and <0.001 respectively). On
the other hand, the level of this parameter after radiotherapy
plus propolis was significantly increased than its corre-
sponding value before treatment (P2 < 0.001) and still signifi-
cantly less than normal control value (P1 < 0.001). MoreoverTable 3 e Statistical analyses of serum RRM2, TAC, MDA and i
breast cancer patients before and after treatment with either r
supplements.
Control group (n ¼ 45) Chem
Radiotherapy alone g
Before
RRM2 (pg/ml)
Range 65e300 460e1500
Mean ± SD 167.48 ± 67.49 714.4 ± 224.7
P1 <0.001
*
P2 <0.001*
P3
TAC (mM/L)
Range 0.81e1.81 0.16e0.72
Mean ± SD 1.34 ± 0.26 0.49 ± 0.15
P1 <0.001
*
P2 0.013*
P3
MDA (nmol/ml)
Range 1.01e3.21 5.30e17.30
Mean ± SD 1.59 ± 0.60 11.77 ± 2.97
P1 <0.001
*
P2 <0.001*
P3
Iron (mg/dl)
Range 113.2e186.7 39.2e122.47
Mean ± SD 140.38 ± 47.85 80.57 ± 22.14
P1 <0.001
*
P2 0.021*
P3TAC levels after radiotherapy plus propolis were significantly
higher than after radiotherapy treatment alone (P3 < 0.001).
Regarding serumMDA levels in both chemotherapy received
BC patients groups, it was significantly higher than normal
control values (P1 < 0.001 and <0.001 respectively). After treat-
ment with radiotherapy alone, serum MDA levels were signifi-
cantly increased than its corresponding value before treatment
(P2 < 0.001) and were significantly higher than normal control
levels (P1 < 0.001). On the other hand, after radiotherapy
treatment plus propolis, serum MDA was significantly
decreased than its corresponding value before treatment
(P2 < 0.001) and still significantly higher than normal control
value (P1 < 0.001). Moreover, it was observed that serum MDA
after radiotherapy plus propolis was significantly lower than
after radiotherapy treatment alone (P3 < 0.001).
With respect to serum iron, it was highly decreased in both
chemotherapy received BC patients groups than normal con-
trol values (P1 < 0.001 and <0.001 respectively). In radio-
therapy alone group, serum iron after radiotherapy
significantly decreased than corresponding values before
treatment (P2 ¼ 0.021) and significantly lower than normal
control levels (P1< 0.001 and<0.001 respectively). On the other
hand, after radiotherapy treatment plus propolis the level of
serum iron was significantly increased than its corresponding
value before treatment (P2 < 0.001) and became within the
normal control value (P1 ¼ 0.915). Furthermore, it was noticed
that, serum iron after radiotherapy treatment plus propolis
supplements was significant higher than after radiotherapy
treatment only (P3 < 0.001).ron in normal control subjects and chemotherapy received
adiotherapy alone or radiotherapy plus propolis
otherapy received breast cancer patients
roup (n ¼ 45) Radiotherapy þ propolis group (n ¼ 45)
After Before After
280e710 330e1450 125e400
477.80 ± 114 661.2 ± 268.27 186.4 ± 79.86
<0.001* <0.001* 0.563
<0.001*
0.286 <0.001*
0.19e0.61 0.13e0.64 0.55e1.90
0.30 ± 0.10 0.43 ± 0.14 0.89 ± 0.24
<0.001* <0.001* <0.001*
<0.001*
0.217 <0.001*
6.17e30.27 5.81e18.65 2.40e10.57
16.12 ± 6.27 11.37 ± 3.03 6.48 ± 2.32
<0.001* <0.001* <0.001*
<0.001*
0.503 <0.001*
34.7e112.17 26.95e92.13 85.2e282.1
65.11 ± 20.73 72.92 ± 17.84 137.8 ± 43.24
<0.001* <0.001* 0.915
<0.001*
0.070 <0.001*
Table 4 e Statistical analyses of hematological parameters in normal control subjects and chemotherapy received breast
cancer patients before and after treatment with either radiotherapy alone or radiotherapy plus propolis supplements.
Control group (n ¼ 45) Chemotherapy received breast cancer patients
Radiotherapy alone group (n ¼ 45) Radiotherapy þ propolis group (n ¼ 45)
Before After Before After
HB (g/dl)
Range 11.30e14.60 10.0e14.10 8.10e12.10 9.80e14.20 7.60e14.60
Mean ± SD 12.50 ± 1.13 12.13 ± 1.04 10.21 ± 0.93 11.88 ± 1.12 11.92 ± 1.42
P1 0.921 <0.001
* 0.563 0.681
P2 <0.001* 0.861
P3 0.081 <0.001*
WBCs (109/L)
Range 4.71e10.60 3.19e9.7 2.10e9.84 3.5e8.68 2.95e10.0
Mean ± SD 6.3 ± 0.84 5.98 ± 1.60 4.01 ± 1.50 6.01 ± 1.66 5.88 ± 1.81
P1 0.571 <0.001
* 0.461 0.380
P2 <0.001* 0.492
P3 0.180 <0.001*
Platelets (109/L)
Range 270e430 192e378 169e367 159e350 230e410
Mean ± SD 323.3 ± 60.1 307.4 ± 72.5 268.1 ± 54.1 300.6 ± 79.6 355.9 ± 115.3
P1 0.451 <0.001
* 0.145 0.213
P2 <0.001* <0.001*
P3 0.574 <0.001*
Fig. 1 e Disease free survival according to propolis
administration in breast cancer patients.
J o u r n a l o f R a d i a t i o n R e s e a r c h and A p p l i e d S c i e n c e s 9 ( 2 0 1 6 ) 4 3 1e4 4 04363.4. Hematological results
Table 4 revealed that, the mean values of hemoglobin con-
centration in the both chemotherapy received BC patients
before treatment either with radiotherapy alone or radio-
therapy plus propolis was nearly within the same range
(P3 ¼ 0.081) and showed insignificant difference with normal
control value (P1 ¼ 0.921 and 0.563 respectively). The level of
this parameter after radiotherapy treatment only was signif-
icantly decreased than its corresponding value before treat-
ment (P2 < 0.001) and still significantly lower than normal
control value (P1 < 0.001). On the other hand, after radio-
therapy treatment plus propolis, hemoglobin concentration
showed insignificant difference with its corresponding value
before treatment (P2 ¼ 0.861) and became within the normal
control level (P1¼ 0.681). Moreover hemoglobin concentration
after radiotherapy plus propolis was significantly higher than
after radiotherapy treatment alone (P3 < 0.001).
As regards white blood cells (WBCs) counts in both chemo-
therapy received BC patients groups, it showed insignificant
difference with normal control value (P1 ¼ 0.571 and 0.461
respectively). The level of this parameter after radiotherapy
treatment only was significantly decreased than its corre-
sponding value before treatment (P2 < 0.001) and still signifi-
cantly lower than normal control value (P1 < 0.001). On the
other hand, after radiotherapy treatment plus propolis, WBCs
counts showed insignificant difference with its corresponding
value before treatment (P2 ¼ 0.492) and became within the
normal control level (P1 ¼ 0.380). Moreover it was noticed that,
WBCs count after radiotherapy plus propolis was significantly
higher than after radiotherapy treatment alone (P3 < 0.001).
As shown in Table 4, the mean values of platelets counts
before radiotherapy treatment in the both chemotherapy
received BC patients groups was nearly within the same range
(P3 ¼ 0.574) and showed insignificant difference with normal
control value (P1 ¼ 0.451 and 0.145 respectively). The level ofthis parameter after radiotherapy treatment only was signifi-
cantly decreased than its corresponding value before treatment
(P2 < 0.001) and still significantly lower than normal control
values (P1 < 0.001). On the other hand, after radiotherapy
treatment plus propolis supplements, platelets counts signifi-
cantly increased than its corresponding value before treatment
(P2 < 0.001) and became within the normal control level
(P1¼ 0.231). Moreover themean values of platelets counts after
radiotherapy plus propolis was significantly higher than after
radiotherapy treatment alone (P3 < 0.001).3.5. The impact of propolis administration on disease
free survival in breast cancer patients
Fig. 1 shows that, breast cancer patients supplemented with
propolis plus radiotherapy had longer median disease free
Table 5 e Test of significance for disease free survival
according to propolis administration.
Median survival
(months)
Log rank
c2 P
Radiotherapy only 23 5.170* 0.023*
Propolis with radiotherapy 27
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alone (23 months). The difference was statistically significant
using log rank test (0.023) (Table 5).4. Discussion
One of the major challenges in cancer research is to discover
non-toxic, selective, and effective cytoprotective compounds
that would preferentially protect normal tissue during radio-
therapy or chemotherapy. These compounds should be
effective against genetic damage, mutation and changes to
the immune system (Benkovic et al., 2009).
Recently, there has been renewed interest in search for
plant derived drug as potential radio-protectors
(Hosseinimehr, 2007). Propolis is a product of great interest,
both in the field of medicine and the pharmaceutical industry
with numerous properties including antioxidant, anti-
einflammatory, immune stimulant, hepatoprotector, and
carcinostatic (Montoro et al., 2010; Viuda-Martos, Ruiz-Nav-
ajas, Fernandez-Lopez, & Perez-Alvarez, 2008). Therefore, we
thought that trying this extract as a radio protective agent
against ionizing radiation (IR) may prove beneficial effect
(Maskey, Lee, Kim, & Kim, 2013). Since BC patients were
exposed to IR, the genotoxic effects of IR were studied in white
blood cells, which circulate throughout the body and which
have been confirmed as a useful biodosimeters by many ra-
diation studies (Lamkowski et al., 2014). The alkaline comet
assay was selected as a sensitive method for detecting DNA
damage produced by known or potentially genotoxic sub-
stances (Garaj-Vrhovac et al., 2002).
The current study demonstrated that radiotherapy is
accompanied by significant increased levels of DNA damage
in peripheral blood leukocyte of BC patients. It was not sur-
prising because IR causes a wide variety of DNA damage
ranging from single and double strand breaks in DNA as well
as DNA basemodifications, oxidative damage and alkali-labile
lesions that can be easily converted into strand breaks during
alkaline denaturation and therefore sensitively detected
(Little, 2000; Singh, 2000). It is known that, besides direct
ionization of DNA, IR also causes an indirect ionization when
free radicals formed as a result of the ionization of water
molecules which damage the DNA (Gamulin, Garaj-Vrhovac,
& Kopjar, 2007).
To avoid the harmful effect of radiations, propolis was
given to chemotherapy received BC patients 10 days before
radiotherapy during the period of receiving radiotherapy and
10 days after completing radiotherapy. The present study
demonstrated the ability of propolis to reduce significantly
the radiation induced DNA damage in peripheral white blood
cells of BC patients received chemotherapy and exposed toIR. This result is expected since propolis has the capability to
stimulate DNA repair mechanisms which in turn counteract
the damage inflicted by IR (Gamulin et al., 2007). The pro-
tective effect of propolis against IR could also be explained by
both the direct scavenging of free radicals produced by the
indirect effect (Orsolic et al., 2007) and the activation of
oxidative repair enzymes (Ramos & Miranda, 2007). Both
scavenger and antioxidant properties are involved in the
protection against induction of DNA damage by IR. This
result suggests that propolis may possess promising radio-
protective effect and may offer a quite measurable protec-
tion against DNA damage caused by IR as detected by alka-
line Comet assay.
A prerequisite for amulticellular organism to survive is the
ability to correctly replicate and repair DNA while minimizing
the number of heritable mutations. To achieve this, cells need
a balanced supply of deoxyribonucleoside triphosphate
(dNTPs) the precursors for DNA synthesis. The rate limiting
step is de novo biosynthesis of dNTPs is catalyzed by the
enzyme ribonucleotide reductase (Hakansson, Hofer, &
Thelander, 2006). The classic eukaryotic RNR enzyme con-
sists of a large RRM1 and a small subunit RRM2. The RRM1
subunit contains the ribonucleotide binding sites and allo-
steric effector sites. The RRM2 subunit contains a non heme
iron complexed with a tyrosyl free radical and is essential for
catalytic activity. A somewhat unusual feature of the RNR
enzyme is that it catalyzes a reaction that proceeds via a free
radical mechanism of action, any agents that scavenge the
tyrosyl radical thereby destabilizing the iron center of RRM2
with a resulting loss of RR enzymatic activity (Barker et al.,
2006).
In the present study, it was found that in group of patients
exposed to radiotherapy only RRM2 levels before and after
completing radiotherapy showed significant difference and
significantly higher than control values, on following those
patients up to 30months 44% of them becamemetastatic with
shorter disease free survival (DFS) time (23 months). This
result suggests that RRM2 may possess oncogene like prop-
erties and plays a potential role in tumor malignancy and
metastasis. This hypothesis is supported by many various
studies. It has been found that overexpression of RRM2
increased the malignancy of H ras transformed fibroblast and
enhance the invasive potential of human cancer cells (Zhou
et al., 1998).
Recently various studies have demonstrated that RRM2
plays additional roles in determining the malignant potential
of tumor cells. For example: elevated expression of RRM2 has
been found to increase the drug resistant properties of cancer
cells and significantly enhance the invasive potential of many
human cancer cells (Gautam, Li, & Bepler, 2003; Zhang et al.,
2011) whereas knockdown of RRM2 results in the reversal of
drug resistance and suppressed tumor growth, and decreased
metastatic potential. Therefore, the upregulation of RRM2
after completing radiotherapy could indicate that RRM2 is
related to the proliferation of cells and may be a malignancy
determinant critically in mechanisms controlling tumor pro-
gression thus delineating the regulatorymechanisms of RRM2
is very important for understanding the control of cell prolif-
eration and cancer and for designing better cancer therapeu-
tics by targeting RRM2.
J o u r n a l o f R a d i a t i o n R e s e a r c h and A p p l i e d S c i e n c e s 9 ( 2 0 1 6 ) 4 3 1e4 4 0438The supplementation of propolis 10 days pre, during and 10
days after completing radiation therapy caused a significant
down-regulation of RRM2 level and becamewithin the normal
control level. Also it was noticed that after 30months only 16%
of these patients became metastatic with longer median DFS
time (27 months) in comparison to patients received radio-
therapy only (23 months). Although a number of agents have
been developed as RR inhibitors, hydroxyurea has received
the most attention in preclinical and clinical studies. Hy-
droxyurea achieved only limited success in clinical trials.
Propolis is an effective iron chelator and disturbs the di-ferric
iron center that stabilizes the tyrosyl free radical, critical for
catalytic function of RRM2 small subunits (Ebrahimzadeh,
Pourmorad, & Bekhradnia, 2008; Gu¨lc¸in, Bursal, S‚ ehitoglu,
Bilsel, & G€oren, 2010). Through this effect, propolis may
potently interfere with RNR function and ultimately
enhancing radiosensitivity of breast cancer cells. This sug-
gestion is consistent with that reported by (Hillman et al.,
2004) who stated that the combination of genisten, one of
propolis component, and radiation enhances radiosensitivity
in human esophageal and cervical cancer cells and exerted
inhibitory effect on DNA synthesis, cell growth and colony
formation.
The mechanisms of radio-sensitization induced by RNR
inhibitor have been assumed to involve cell cycle synchroni-
zation and/or inhibition of DNA repair. Propolis supplemen-
tation results in an accumulation of cells in G1, and
preferentially kills cell in S phase (Sawicka, Car, Borawska, &
Niklinski, 2012). An apparent radio-sensitization may occur
because cells in S phase aremore radio-resistant than those in
G1. The result of the present study suggests the beneficial
effect of propolis in cancer radiotherapy.
In the present study, TAC in serum of patients received
radiotherapy only either before or after completing radio-
therapy was significantly lower than in normal control group.
Radiotherapy treatment leads to significant decrease in serum
TAC. Similar to our study, other researchers reported a sig-
nificant decrease of serum TAC after treatment of children
with malignancy, with standard chemotherapy which was
associated with increased ROS (Papageorgiou et al., 2005). The
reduction in TAC could reflect consumption of endogenous
antioxidants by free radical generation by disease process or
treatment itself. Insufficient dietary intake of exogenous an-
tioxidants during the treatment period might have also
contributed.
The present biochemical study revealed that lipid peroxi-
dation in the form of malondialdehyde (MDA) which is a good
indicator of the degree of membrane lipid peroxidation, was
significantly higher in BC patients than in normal control
group and significantly increased to comparable extent after
completing radiotherapy as compared to pre radiotherapy,
indicating the presence of radiation induced oxidative dam-
age. Our reasonable explanation is that, IR causes hydrolysis
of water generating hydroxyl radicals (OH_). OH_ is considered
as the most damaging of all free radicals generated in organ-
isms and reacts readily with most cellular components
including organic molecules (Jagetia, Rajanikant, Rao, &
Baliga, 2003). Its reaction with polyunsaturated fatty acids of
membrane phospholipids and with lipid hydroperoxides are
characterized by extremely high rate constants and produce avariety of compounds such as malondialdeliyde, 4 hydroxy
non enol and acrolin (Gutteridge, 1995) that may exert more
toxic effects on cells including alterations in the structure and
function of cell organelles (Rosen, Vinter,& Goldberg, 1989). In
light of these results, the reduction in TAC and elevation in
lipid peroxidation suggested an increased level of oxidative
stress in BC patients received radiotherapy.
In the current study, it was observed that propolis
administration plus radiotherapy significantly lowered the
radiation induced lipid peroxidation in terms of MDA pro-
duction and led to a significant increase in TAC capacity. On
the basis of the results of this study, it is clear that propolis has
comparable reducing power and antioxidant activity, since it
is composed of nutritionally valuable substances and contains
considerable amounts of polyphenols substance which may
act as potent antioxidant.
Concerning the toxic effect of ionizing radiation on he-
matological parameters, the present study displayed that
radiotherapy resulting in a highly significant decrease in the
number of WBCs, platelets and significant fall in Hb concen-
tration, which may be due to alternation in bone marrow as
well as hemopoietic system of BC patients group. Similar ob-
servations were obtained by (Osman & Hamza, 2013).
The decrease in the values of hematological parameters
may be assigned to direct damage caused by IR (Heda& Bhatia,
1986). The cellular elements of the blood are particularly
sensitive to oxidative stress because their plasmamembranes
contain a high percentage of polyunsaturated fatty acids
(PUFA) (Chew & Park, 2004). Therefore, the decrease in WBCs
count might be the consequence of radiation induced lipid
peroxidation and damage of their cell membranes or may be
attributed tomitotic inhibition of the bonemarrow precursors
and/or direct destruction of mature circulation cells
(Ramadan, 2007). The observed decline in the total leukocytic
count was in agreement with (Abdelhalim & Moussa, 2013).
The decrease in Hb concentration was due to changes in
erythrocyte membrane emphasizes the formation of free
radicals. The effect of free radicals on erythrocyte membrane
may contribute to the eventual leak of hemoglobin out of the
cells (Hussien, Darwish, & Ali, 2007).
On the other hand, group of patients received propolis
plus radiotherapy showed a significant improvement of
WBCs count, Hb concentration and platelets count and sig-
nificant increase in serum iron. Propolis induced extensive
proliferation of hematopoietic cells in the spleen and bone
marrow (Orsolic & Basic, 2005). Moreover, it improves the
digestive utilization of iron and increases the regeneration
efficiency of hemoglobin especially during recovery from an
anemic syndrome (Haro et al., 2000). In addition, the high
content of flavonoids in propolis improves and accelerates
the generation of erythrocyte and hemoglobin (Harrison,
Shasha, White, & Ramdeen, 2000). Moreover, the adminis-
tration of propolis was found to modulate the peripheral
blood mononuclear cells (PBMCs) mitogenic responses
which was suggested to be due to the presence of immuno-
regulatory components (Harish, Rubinstein, Golodner,
Elmaliah, & Mizrachi, 1996). The results obtained from this
study highlight the possible protective role of propolis
against radiation-induced damage to the hematopoietic
system and may help to prevent anemia.
J o u rn a l o f R a d i a t i o n R e s e a r c h and A p p l i e d S c i e n c e s 9 ( 2 0 1 6 ) 4 3 1e4 4 0 4395. Conclusions
 Supplementation of propolis with radiotherapy treatment
offer a quite measurable protection against DNA damage
caused by ionizing radiation in patients leukocytes.
 It seems reasonable to predict that propolis may potently
interfere with RNR function and ultimately enhancing
radio-sensitivity of breast cancer cells.
 These results nominate propolis to be a good agent to
attenuate radiation induced lipid peroxidation and hema-
tological damage.
 This study may lay a foundation for the potential future
use of propolis in combinationwith radiotherapy to protect
normal cells from radiation induced oxidative stress.
 Larger prospective studies are required to confirm our
findings.Conflict of interest
No conflict of interest is declared.
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